Exploring the MicroRNA Landscape in Cardiac Amyloidosis: Molecular Insights and Clinical Applications
Genes · 23.03.2026 · 17 (3) · 356
DOI: 10.3390/genes17030356 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 23.03.2026. Verfasst von Joanna E Kontaraki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cardiology Laboratory, School of Medicine, University of Crete, 70013 Heraklion, Crete, Greece. Hauptthemen laut MEDLINE: MicroRNAs, Amyloidosis, Cardiomyopathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiac amyloidosis (CA) is an increasingly recognized cause of heart failure with preserved ejection fraction, resulting from myocardial deposition of misfolded amyloid fibrils derived predominantly from transthyretin (ATTR wild-type [ATTRwt] or variant [ATTRv]) or immunoglobulin light chains (AL). Despite advances in noninvasive imaging and disease-modifying therapies, delayed diagnosis remains common, and clinically actionable molecular biomarkers for early detection, phenotypic discrimination, and therapeutic monitoring are limited. MicroRNAs (miRNAs), small noncoding regulators of post-transcriptional gene expression, have emerged as key modulators of cardiovascular remodeling and systemic amyloid biology.
Methods
We performed a comprehensive review of experimental, translational, and clinical studies to evaluate the role of miRNAs in transthyretin and light-chain cardiac amyloidosis, incorporating data from myocardial tissue analyses, circulating miRNA profiling, and mechanistic studies in cellular and animal models.
Results
Dysregulated miRNA networks contribute to amyloid-induced cardiac injury by modulating mitochondrial energetics, oxidative stress, inflammation, fibrosis, proteostasis, and neurocardiac signaling. Specific miRNAs, including members of the miR-21, miR-29, and miR-30 families, as well as miR-150-5p and miR-339, have been associated with amyloid burden, adverse myocardial remodeling, plasma cell biology, and disease severity. Distinct circulating and tissue miRNA signatures differentiate transthyretin from light-chain cardiac amyloidosis and correlate with functional status, heart failure biomarkers, and clinical outcomes.
Conclusions
MiRNAs represent promising diagnostic and prognostic biomarkers in cardiac amyloidosis and offer mechanistic insights into disease pathogenesis. Integration of miRNA profiling with multimodality imaging and emerging RNA-based therapeutics may enable earlier diagnosis and support precision management of amyloid-related heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Cardiology Laboratory, School of Medicine, University of Crete, 70013 Heraklion, Crete, Greece.
- Cardiology Department, Heraklion University General Hospital, 71500 Heraklion, Crete, Greece.
ORCID-Profile: Joanna E Kontaraki, Anthoula Plevritaki, Aleksi Sallo, Konstantinos Fragkiadakis, Eleutherios Kallergis, Emmanouil Kampanieris, Maria E Marketou
Zitieren
APA
Kontaraki, J. E., Plevritaki, A., Sallo, A., Fragkiadakis, K., Kallergis, E., Zacharis, E., Kopidakis, J., Kampanieris, E., Achladianaki, S., Papakosta, V., Simantirakis, E., & Marketou, M. E. (2026). Exploring the MicroRNA Landscape in Cardiac Amyloidosis: Molecular Insights and Clinical Applications. Genes, 17(3), 356. https://doi.org/10.3390/genes17030356
Vancouver
Kontaraki JE, Plevritaki A, Sallo A, Fragkiadakis K, Kallergis E, Zacharis E, et al. Exploring the MicroRNA Landscape in Cardiac Amyloidosis: Molecular Insights and Clinical Applications. Genes. 2026;17(3):356. doi:10.3390/genes17030356
BibTeX
@article{Kontaraki2026,
author = {Kontaraki, Joanna E and Plevritaki, Anthoula and Sallo, Aleksi and Fragkiadakis, Konstantinos and Kallergis, Eleutherios and Zacharis, Evangelos and Kopidakis, John and Kampanieris, Emmanouil and Achladianaki, Sophia and Papakosta, Vasiliki and Simantirakis, Emmanouil and Marketou, Maria E},
title = {Exploring the MicroRNA Landscape in Cardiac Amyloidosis: Molecular Insights and Clinical Applications},
journal = {Genes},
year = {2026},
volume = {17},
number = {3},
pages = {356},
doi = {10.3390/genes17030356}
}
EUVIMED